YuanBio Venture Capital
Venture capitalSuzhou · Seed–Growth · 8 people tracked
Investment thesis
YuanBio invests in highly innovative healthcare companies across China at early and growth stages while maintaining a global perspective on industry developments. Its focus spans biotech, medical devices, IVD and healthcare services. The firm leverages its base in Suzhou bioBay and close ties with the bioBay platform for high-quality deal flow, information exchange and post-investment support. Its team combines scientific expertise, industry experience and early-stage investment knowledge, supported by senior experts and consultants. YuanBio adds value through business development, management and operations, fundraising, and recruitment assistance, aiming to become one of China's most successful healthcare venture capital firms.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 10 of 73 portfolio companiesHealthtech ×8Biotech ×7Medical Devices ×7Digital Health ×3Hardware ×2Advanced Manufacturing ×1Deep Tech ×1Developer Tools ×1
HQs:China×7United States×1
Investments · 73 tracked
founders shown can be your intro path
Co-investorsQiming Venture PartnersVivo Capital
MacroLux Medical Technology develops endoscopic imaging systems and related medical devices.
HardwareHealthtechMedical DevicesShenzhen, CN
Co-investorsDalton VentureLegend CapitalB Capital GroupB4 Capital
Provider of R&D and one-stop production services to leading pharmaceutical companies worldwide.
Co-investorsHongShan Capital Group
Reproductive health specialist reportedly planning a Hong Kong IPO.
Reproductive-medicine specialist planning a Hong Kong IPO.
Overseas medical and aesthetic laser equipment maker that closed new funding.
Co-investorsGreen Pine Capital Partners
A biopharmaceutical company developing CAR-T cell therapies for cancer treatment.
BiotechHealthtechMedical DevicesShanghai, CN
Co-investorsAcorn Pacific VenturesARCH Venture Partners
PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders.
BiotechHealthtechHangzhou, CN
Quantum-Si develops next-generation protein sequencing technology that enables single amino acid detection by combining biology, chemistry, artificial intelligence, and semiconductor technology.
BiotechDeep TechHardwareMedical Devices
Jeff Hawkins(CEO)Jeff Keyes(Chief Financial Officer)Christian LaPointe(General Counsel)Todd Rearick(Chief Technology Officer)Lindsay Thompson(Chief Human Resources Officer)
Co-investorsForesite CapitalHighCape Capital
Shuwen Biotech develops molecular and immunodiagnostic products for women's health, including breast cancer subtyping kits, nucleic acid extraction systems, and point-of-care tests for pregnancy complications.
BiotechDigital HealthFemTechHealthtechMedical DevicesShanghai, CN
Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases.
BiotechHealthtechLongevityWaltham, US
Dr. Xiaodong Wang(Founder)Dr. Zhiyuan Zhang(Founder)
Co-investorsARCH Venture PartnersF-Prime CapitalFuture Innovation
Co-investorsQiming Venture Partners
TriApex provides contract research organization (CRO) services supporting pharmaceutical and biologics development, including preclinical studies, clinical trial design, regulatory strategy, and post-market safety monitoring.
BiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesNanjing, CN
Co-investorsApricot Capital
Jiangsu Wanhe Technology Group is a custom software development service provider offering native app and mini-program development, e-commerce platform building, and high-end brand website design for business clients.
Developer ToolsE-commerceSaaSSuzhou, CN
Exits · 2
IPOs and acquisitions across the tracked portfolioAdlai NortyeNASDAQ: ANLZai LabNASDAQ: ZLAB
Portfolio news
latest coverage across their companiesJW Therapeutics · tipranks.com · Jun 26, 2026
Sironax · sironax.com · Nov 19, 2025
MacroLux · microlite.cn · Oct 23, 2025
Frequently asked questions
- How many investments has YuanBio Venture Capital made?
- YuanBio Venture Capital has 72 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does YuanBio Venture Capital invest at?
- YuanBio Venture Capital invests at the Seed, Series A, Series B, Growth stages.
- What is YuanBio Venture Capital's typical check size?
- YuanBio Venture Capital typically writes checks of $3M – $73M.
- What sectors does YuanBio Venture Capital focus on?
- YuanBio Venture Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is YuanBio Venture Capital located?
- YuanBio Venture Capital is headquartered in Suzhou, CN.
- Does YuanBio Venture Capital lead rounds?
- YuanBio Venture Capital typically participates in rounds rather than leading them.
- Who does YuanBio Venture Capital co-invest with?
- YuanBio Venture Capital most often shares deals with ARCH Venture Partners, Qiming Venture Partners, F-Prime Capital, among 9 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.